SLGC
Somalogic Inc
19.10$
-0.4%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -33.2% | +4.9% | +1.1% | +15.0% | -0.1% | -38.5% | +194.9% | -54.9% | +8.2% | +0.4% | +7.7% | – | |
| – | -39.0% | +27.9% | +9.8% | +19.3% | +11.4% | -39.3% | +64.9% | +11.1% | -5.0% | -9.3% | +4.1% | – | |
| – | -29.9% | -6.5% | -4.9% | +11.7% | -9.6% | -37.6% | +325.1% | -80.5% | +37.5% | +15.3% | +12.1% | – | |
| – | +7.3% | +5.8% | +81.6% | -28.2% | +23.3% | +27.8% | +10.1% | +16.3% | -37.7% | -23.1% | -3.3% | – | |
| – | – | -93.8% | +3,583.0% | -97.3% | +5,219.5% | +3.3% | +16.7% | -33.1% | +35.8% | -12.4% | -41.4% | – | |
| – | +18.3% | +11.9% | +54.7% | +12.9% | +9.1% | +22.0% | +29.8% | -14.6% | -20.0% | -16.3% | -15.0% | – | |
| – | -2,936.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -86.6% | -87.4% | -98.6% | +7,150.0% | +20,112.4% | -16.8% | -71.1% | +734.8% | -89.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -87.3% | +45.8% | +860.4% | -99.8% | -77,226.3% | – | – | – | – | +0.0% | +23,800.0% | – | |
| – | – | – | – | – | – | -94.4% | -2,434.7% | – | – | – | – | – | |
| – | -1,416.4% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.